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Abstract 
The Charcot knee - or neuropathic arthropa-
thy - presents a considerable challenge to the
orthopaedic surgeon. Caused by a combination
of sensory, motor and autonomic neuropathy, it
was originally described as an arthritic seque-
lae  of  neurosyphilis.  In  today’s  western
orthopaedics it is more often caused by dia-
betes. A Charcot knee is often symptomatically
painful and unstable. Traditional management
has usually been conservative or arthrodesis,
with limited success. Arthroplasty of a Charcot
joint has commonly been avoided at all costs.
However, in the right patient, using the right
technique,  arthroplasty  can  significantly
improve the symptoms of a Charcot joint. This
article explores the evidence surrounding the
role of arthroplasty in the management of a
Charcot knee. Arthroplasty is compared to other
forms of treatment and specific patient demo-
graphics and surgical techniques are explored
in an attempt to define the role of arthroplasty
in the management of a Charcot knee. 
Introduction
The Charcot joint or neuropathic arthropa-
thy  was  first  described  by  Charcot  as  an
arthritic sequelae of neurosyphilis. It results in
significant  joint  destruction  and  instability.
Albeit rare, a Charcot knee presents a consid-
erable challenge to the orthopaedic surgeon.
Literature surrounding the Charcot knee and
especially the role of arthroplasty in its man-
agement is limited and in some respects con-
tradictory. This article will attempt to summa-
rize the evidence concerning arthroplasty and
the Charcot knee.
Pathophysiology
The  pathophysiology  of  a  Charcot  joint  is
still not fully understood. Two theories current-
ly exist; the French and German theories. The
first  supports  the  idea  that  the  osteopenia
associated with a Charcot joint results from
autonomic dysfunction. This dysfunction leads
to increased blood flow to the joint caused by
decreased sympathetic tone from damage to
the trophic centres.
1-4 This theory is well sup-
ported by perfusion and temperature studies of
neuropathic  joints.
5 A  five-fold  increased  in
perfusion with diabetic neuropathy has been
noted. This increased perfusion is only mini-
mally affected with sympathetic arousal stim-
uli in those with non-painful neuropathy. This
is in contrast to those with painful neuropathy,
where sympathetic arousal stimuli are effec-
tive vasoconstrictors.
5
The  German  theory  implicates  trauma  as
the  underlying  cause  of  joint  disease.
6 The
patient’s decreased nociceptive response due
to neuropathy, coupled with ongoing activity
and  micro-trauma,  results  in  joint  and  liga-
ment damage. This trauma ignites the body’s
inflammatory response causing further defor-
mity through bony resorption.
7
A combination of the two theories provides a
viable explanation for the pathogenesis of neu-
ropathic  joint  disease.  The  Charcot  joint  is
likely to be a result of co-concomitant sensory,
motor and autonomic neuropathy. The sensory
neuropathy  results  in  decreased  sensation,
proprioception and protective reflexes to the
joint, leading to damage from undetected trau-
ma.  The  motor  neuropathy  results  in
decreased support for the joint, exacerbating
instability. The autonomic neuropathy increas-
es blood flow to the joint, causing resorption
and subsequent osteopenia of the bone.
8-11
Demographics
Charcot’s description of the disease implicat-
ed  tertiary  syphilis  as  the  underlying  cause.
Many other diagnoses resulting in a neuropath-
ic arthropathy have thereafter been identified.
These  include  leprosy,  alcoholism,  syringo  -
myelia, lacunar infarct,
12 hereditary cerebral and
cerebellar  atrophy
13 and,  more  commonly  in
modern times, diabetes mellitus (DM).
14
The distribution of the neuroarthropathy is
partly  determined  by  its  underlying  cause.
Tertiary syphilis often affects large weight bear-
ing joints such as the knee. Syringomyelia more
commonly afflicts the joints of the upper extrem-
ity such as shoulder and elbow.
7 Diabetes melli-
tus is more likely to affect the foot and ankle.
7
With increasing use of antibiotics, syphilis
as a cause of neuroarthropathy is declining. In
the modern age, diabetes has taken over as the
major cause of the Charcot joint.
12,15 A patient
suffering from DM has a 7.5% chance of suffer-
ing  from  neuroarthropathy.  This  number
increases  almost  4-fold  in  patients  with  co-
concomitant peripheral neuropathy.
16
Due to the epidemiological change of under-
lying cause from syphilis to DM, the ankle and
feet are now more commonly affected than the
knee.
14 In a series of patients suffering from
neuroarthropathy as a result of DM, only 6% of
the  affected  joints  were  knees.  The  majority
(64%) of affected joints were feet.
14 Hence, in
effect, 0.45% of all diabetic patients are likely to
suffer from neuroarthropathy of the knee. This
should be kept in mind when a diabetic patient
presents  with  a  diagnosis  of  osteoarthritis
seeking  joint  replacement.  With  the  ever
increasing number of diabetic patients in the
western world and the limited literature regard-
ing the treatment of a Charcot knee, the neu-
roarthritic  knee  may  once  again  present  as
common surgical problem in the near future. 
Signs and symptoms
Neuropathic  arthropathy  has  classically
been  described  as  a  painless  arthropathy.
However pain and instability are the two major
presenting complaints of the Charcot knee suf-
ferer. Mild to moderate pain is usually felt early
in  the  course  of  the  disease,  during  the
destructive  process.
17 This  pain  is  usually
worse on walking and rare during rest.
18 The
degree of pain does not correspond with the
level of joint destruction. This results in neuro-
pathic arthropathy’s classic description as rel-
atively painless.
7 The instability is attributed to
the  decreased  proprioception  leading  to
extremes of range of motion, ligamentous lax-
ity, effusion and bony destruction.
7,12 Loss of
deep tendon reflexes is common in this popu-
lation, especially when syphilis is the underly-
ing cause.
19 Oedema and joint temperature are
indicative  of  the  stage  of  the  disease.  A
Charcot  joint  has  been  reported  to  undergo
three phases, largely determined by the radi-
ographic findings (see below). The first phase
(developmental phase) is clinically character-
ized by strong pulses and a red, hot, oedema-
tous joint. In the next two phases (coalescent
and reconstruction phases) the joint tempera-
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side, and the oedema begins to resolve.
4
Investigations
An x-ray is a useful tool in diagnosing and
determining  the  extent  of  joint  disease.
Findings of subluxation, fragmentation, bony
destruction and the presence of periarticular
bone formation are all common in a Charcot
joint
12 (Figures 1 and 2). Acute destruction and
periarticular fragmentation of bone is seen in
the developmental phase. The bony debris is
seen to be absorbed and sclerosis evident in
the coalescent phase. This progresses to radio-
logical  signs  of  fusion  in  the  reconstructive
phase.
4 It is important to recognize the phase
of disease as it has bearings on management. 
Further imaging using a CT or MRI does not
add much clinical significance. An MRI can be
useful in excluding other pathology. A Charcot
joint usually exhibits low signal intensity on
both T1 and T2 weighted images. High signal
intensity in T2-weighted imaging can indicate
the presence of osteomylitis, tumours, trauma
or osteonecrosis.
20
The diagnostic gold standard for a Charcot
joint still remains the histological appearance
of fragments of bone and cartilage embedded
within the synovium.
10,21,22
Non-arthroplasty management
Non-operative
Conservative  management  is  preferred  in
this  subset  of  patients,  as  surgical  manage-
ment can be difficult and demanding.
The role of conservative management is to
prevent further injury to the joint.
7 The main-
stay of treatment is to instigate a non-weight-
bearing regime as soon as possible, especially
in the early destructive phase.
4,7,9,14Non-weight-
bearing can be augmented with elimination of
movement at the joint either via a brace, plas-
ter  or  total  contact  cast.
4,7,9,14,23 A  non-weight-
bearing period of 3 months has been recom-
mended by some.
7 Early conservative manage-
ment may alter the progression of certain neu-
ropathic disorders.
4,22
Adjuncts  to  conservative  management
include the use of bisphosphonates and low
intensity  ultrasound.  Bisphosphonates  have
been reported to help stop osseous destruction
by preventing bony resorption. In one study, six
patients  with  neuropathic  arthropathy  were
treated with bisphosphonates and monitored
using temperature sensors. This resulted in a
reduced temperature reading in all 6 patients
within 2 weeks.
24 This was verified with a ran-
domized control trial of 39 patients comparing
bisphosphonates  with  placebo.  The  active
group was found to have significantly reduced
bone  turn-over,  disease  activity  and  conse-
quently symptoms.
25However, more research is
needed to substantiate the effectiveness of bis-
phosphonates in neuropathic arthropathy. Low
intensity ultrasound is thought to be beneficial
in the management of a Charcot foot; hence its
use may also be applicable to the knee.
17 Again,
more research is required to determine effica-
cy. Failure of conservative measures is com-
mon due to the difficulty in minimizing severe
instability and shearing stress.
19
Arthrodesis
The severe instability, soft-tissue laxity and
bony  destruction  often  renders  conservative
management as futile and arthroplasty as high
risk.
23 Hence, the surgical treatment of choice
has classically been arthrodesis.
14,19,22 Once the
destructive  phase  has  radiologically  ceased
and bone reconstruction has started, then sur-
gical intervention can be considered.
14
Arthrodesis is commonly achieved using an
intramedullary nail.
19,23 The patella, along with
the entire synovium is usually excised. Any
remaining synovium may fibrose and act as a
vascular barrier, resulting in shunting of blood
around the fusion site and hence preventing
fusion. Careful removal of cartilage and scle-
rotic bone follows. A rod is then inserted with
the bony edges apposed at 10-20 degrees. The
limb is immobilized using a long leg cast in
neutral  rotation.  Post  operative  orders
includes non-weight bearing status until the
knee is clinically and radiologically fused.
19 A
study of 10 patients treated with fusion result-
ed in successful fusion in the 9 patients who
were followed up. Three patients developed an
infection, which cleared by time passing. No
nail was reported as broken during the follow-
up period ranging from one to 23 years.
19
Arthroplasty of the 
Charcot knee
Population
Arhtroplasty of a Charcot knee is challeng-
ing at best, and some consider the diagnosis as
an absolute contraindication to arthroplasty.
26-28
If arthroplasty is decided as the management
pathway of choice, then some patient consider-
ations must be made prior to surgery. 
As  with  any  joint,  the  degree  of  joint
destruction  determines  the  difficulty  of  the
operation and the success chance.
23Those with
milder deformities have generally fared much
better with fewer complications.
22,29
The phase of the disease is also an important
factor  to  consider.  The  disease  should  have
completely passed its destructive phase before
surgical intervention can be considered. This
can  be  determined  radiologically  using
Eichenholtz’s stages of disease
9 with the cessa-
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Figure 1. Charcot knee anteroposterior view x-ray. Figure 2. Charcot knee lateral view x-ray.
[page 66] [Orthopedic Reviews 2010; 2:e17][Orthopedic Reviews 2010; 2:e17] [page 67]
tion of destruction indicated by the final radio-
logical stage of reconstruction.
29 Arthroplasties
performed before this stage risk complications
of dislocation of prosthesis and implant frac-
tures.
30 Arthroplasty should only be considered
in  patients  showing  radiological  evidence  of
bony reconstruction.
14,18
The  final  consideration  is  the  underlying
cause of the disease. Traditionally, the popula-
tion most affected with the Charcot knee were
sufferers of syphilis. This subset of patient has
the risk of deteriorating and developing ataxia.
This would have a detrimental effect on any
performed  arthroplasty,  due  to  uneven  and
abnormal stress exerted on the joint.
30,31 With
the  modern  patient  demographic  suffering
predominantly from diabetes mellitus, it is dif-
ficult to say whether they will respond in the
same way as those suffering from syphilis.
32
If  all  the  considerations  mentioned  above
are taken into account, then arthroplasty can
be  considered  a  suitable  option  for  sympto-
matic neuropathic knee.
12,13,22
Although a few case series do report good
results  from  arthroplasty,  most  case  series,
unfortunately, do not indicate which patients
had been excluded from joint arthroplasty. It is
therefore difficult to ascertain the risk of offer-
ing knee arthroplasty to all patients (Table 1).
12
Benefits
The benefits of arthroplasty for the sufferer
of a neuropathic knee are many. 
Arthroplasty has been very successful in the
treatment of pain relief. In one study, arthro-
plasty resulted in 92% of patients having no or
only mild pain, compared to 15% pre-operative-
ly.  The  number  of  those  with  severe  pain
dropped from 10 knees to 1 post-operatively.
12
In terms of functional outcome, all reports of
functional scores have significantly improved
with arthroplasty.
12,18,22 These include average
post-operative score gains of 42,
22 39.5,
18 and
40
13 points. The change in range of motion was
not consistent amongst case series. In some it
increased,
12 in others it decreased.
18 But with
both series, pre-operative range of motion was
not noted as a significant problem. In a few
patients (three knees), hyperextension of the
knee was noted post-operatively, but no recu-
vatum was evident at final follow-up.
12
Alignment is an import factor for increased
longevity of prosthesis and prevention of insta-
bility
33 (Figure  3).  Arthroplasty  is  capable  of
improving alignment in neuropathic knees. On
average alignment improved in all case series.
The preoperative alignment averaged at 9.18
degrees varus in one series, and this improved
to 6.18 degrees valgus post arthroplasty.
12 In
other  series,  the  alignment  improved  to  7.4
degrees of valgus.
18 In most cases the patella
was  located  centrally.
12,18 Other  benefits  of
arthroplasty compared with different forms of
management include decreased need for rest
and non-weightbearing orders, decreased bone
loss  and  ability  to  convert  to  arthrodesis  if
arthroplasty fails, given an uncemented com-
ponent is used.
13 In functional terms, the above
translates to multiple cases whereby patients,
who had previously been disabled to such an
extent  that  they  were  unable  to  walk,  were
then able to do so post-operatively, although
still requiring support.
18
Complications
Arthroplasty  performed  on  a  neuropathic
knee  is  at  greater  risk  of  complications.
12,14
This increased risk is a combination of a high-
er incidence of the common complications of
knee  arthroplasty,  with  an  added  subset  of
complications that are specific to this group. 
A  review  of  the  available  literature  reveals
that the total complication rate is approximately
50%  (35  complications  on  72  knees).
12-14,18,22,23
This is remarkably higher than that of arthro-
plasty performed for OA. 
The list of complications included 5 knees
(7%)  suffering  dislocations.  Patellar  disloca-
tions were treated with a lateral release and
those  suffering  tibiofemoral  dislocations  (3
knees)  were  treated  successfully  with  six
months  of  bracing.
18 Five  knees  suffered
periprosthetic fractures (7%), requiring open
reduction  and  internal  fixation.  Four  knees
were showing signs of loosening and instabili-
ty. The rate of deep venous thrombosis (DVT)
was also remarkably high with 6 knees (8%)
suffering DVTs. Other rarer but serious compli-
cations included disruption of the quadriceps
Table 1. Neuropathic arthropathy of the knee treated with arthroplasty. 
Study Year  No. of  Underlying cause Management Prosthesis Complications Outcome
knees
Vince23 2005 1 Syphilis Arthroplasty Constrained Dislocation, infection (MRSA) Prosthesis removed
Parvizi12 2003 40 Familial sensorimotor  Arthroplasty Longstem (27), Avulsion of tibial tubercle,  Thirty-four (85%)
deficit (16), diabetes  Rotating hinge (5), patellar tendon rupture,  Free of revision at 8 years,
(DM) (7), syphilis (4),  Cruciate condylar (8) loosening (1), 6 revisions  Thirty-three (82.5%)
lacunar infarct (1),  (aseptic loosening x2,  free of mechanical failure
syringomyelia (1),   (3 and 7 years post),
idiopathic (11) instability x1 (1 year post), 
infection x1, arthrodesis for 
periprosthetic fracture x1, 
periprosthetic fracture x 
another 1), MCL avulsion (x2), 
symptomatic instability (x3), 
haematoma x2, superficial 
infection x1, DVT x1
Kim18 2002 19 Syphilis Arthroplasty Hinged (1),  Loosening (1), Only 53% were satisfactory
semiconstrained (1),  Dislocation (4), at a mean follow-up of 5 
condylar, constrained (17) Peri-prosthetic fracture (3) years.
Rupture of the quadriceps Two awaiting arthrodesis
tendon (1)
Fullerton14 1997 2 Diabetes mellitus Arthrodesis (1),  Highly constrained Haematoma (1) Satisfactory
Arthroplasty (1) rotating hinge
Chong13 1995 1 Hereditary cerebral  Arthroplasty Unknown Nil Satisfactory at 2.5 years
and cerebellar atrophy 
Soudry22 1986 9 Arthroplasty PS condylar (2),  DVT (5) Satisfactory at 3 years
Custom prosthesis (7) 
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mechanism in 3 knees, and deep infection in 2
knees.  Disruption  of  the  quadriceps  mecha-
nism  could  be  attributed  to  the  difficulty  in
exposure of these severely deformed knees and
was treated with intraoperative repair, required
immobolization post-operatively.
12
The above mentioned complications result-
ed in 11 (15%) knees requiring subsequent
surgery.  It is a widely held belief that neuro-
pathic arthropathy secondary to syphilis will
result in a much higher complication rate.
12,23
Apart from intraoperative and short-term com-
plications, patients with syphilis may deterio-
rate and develop ataxia, which could adverse-
ly affect the replaced joint.
12 A comparison of
the  two  largest  studies  of  neuropathic
arthropathy treated with arthroplasty reveals
that the syphilis cohort did seem to suffer a
larger  proportion  of  complications.  This
increase was moderately large but not cata-
strophically so. In Kim’s
18 cohort of 19 neuro-
pathic knees with syphilis as the underlying
cause,  8  serious  complications  were  noted;
while  in  Soudry’s
22 series  of  40  patients,  of
which only 4 suffered from syphilis, 12 serious
complications where noted.
12,18 In terms of sat-
isfactory  long-term  outcome,  82.5%  of
Soudry’s cohort was free from mechanical fail-
ure at 8 years, while only 53% of Kim’s syphilis
afflicted knees had a satisfactory outcome at 5
years. 
Technique
To minimize complications for this high-risk
group  of  patients,  certain  fundamental  tech-
niques have been mentioned in the literature.
Before arthroplasty is even considered in a
patient  with  neuropathic  arthropathy,  it  is
important  to  council  the  patient  first.  The
patient must be aware of the risks involved in
such a procedure and the high possibility of
failure and its implications. The patient should
understand that arthrodesis and even amputa-
tion are possible outcomes if arthroplasty is
attempted.
13 Only then should arthroplasty be
considered. Prior to the operation, it is recom-
mended antibiotics and anti-thromboembolics
to be used routinely in these patients.
12
A few key intra-operative steps may increase
the  likelihood  of  long-term  success.  Charcot
knees are characterized by their severe defor-
mity, bone loss and consequent ligamentous
instability.  Apart  from  the  routine  steps  of
arthroplasty,  realigning  the  knee,  fixing  the
bony defects and meticulous ligament balanc-
ing are essential. Bony defects and the exten-
sive  bone  fragmentation  associated  with  a
Charcot  knee  are  present  in  approximately
90%  of  cases.
12 In  approximately  half  of  the
patients  with  neuropathic  arthropathy,  such
defects were greater than 10 mm in the lateral
tibial plateau post medial plateau resection.
18
These  bony  defects  need  to  be  filled  and/or
reinforced. This can be achieved through bone
grafting, either autologous or synthetic
12-14,18 or
through custom augments.
12,14,22Autologus bone
graft can be acquired from the excised femoral
condyle or tibial plateau.
18
Realignment of the joint will require liga-
ment balancing and probable lateral release. In
some  cases  the  requirements  of  balancing
have  been  so  great  that  neurolysis  of  the
popliteal nerve could not be avoided. Resection
of the iliotibial band, lateral ligament, lateral
gastrocnemius and biceps tendon may also be
needed.
13 The quadriceps mechanism is almost
always  malaligned  and  requires  a  lateral
release  to  correct.
12-14,18 Occasionally,  tibial
tubercle  transfer  is  warranted.
12 Quadriceps
mechanism rupture is a noted complication of
this patient cohort due to difficulty in expo-
sure.
12 Finally a complete synovectomy is rec-
ommended.
13,14,18 The synovium is hypothesized
to interfere with normal bone metabolism and
Article
Figure 5. Long-stem prosthesis lateral view
x-ray.
Figure  4.  Long-stem  prosthesis  ante  -
roposterior view x-ray.
Figure 3. Long leg standing x-rays showing
significant malalignment.increase  the  likelihood  of  surgical  interven-
tion.
22 Post-operative orders are dependent on
intraoperative findings. The majority of knees
will require bracing and restricted weightbear-
ing for a period of time after the operation.
12
This  is  to  prevent  any  damage  to  the  bony
repair and ligament balancing. Post-operative
ligament  laxity  may  likewise  require  brac-
ing.
12,13 Like  all  knee  replacements,  range  of
movement exercises should begin early.
12
Prosthesis
The choice of prosthesis can be difficult in
arthroplasty of the neuropathic knee. Like all
arthroplasty, the choice of prosthesis is usual-
ly dictated by the level of joint deformity. With
the neuropathic joint, this level of deformity
can be substantial.
Most would agree that a condylar type pros-
thesis is the most appropriate choice for most
knees.
12,18,22 Examination  of  previous  studies
shows  that  condylar  type  prostheses  have
fewer  complications  compared  with  other
prosthesis.
12,34 However, bony destruction can
be extensive in a neuropathic knee; the sur-
geon  should  therefore  always  consider
whether a constrained or hinged prosthesis is
to be used.  Parvizi
12 warns that a less con-
strained device may lead to symptomatic insta-
bility, requiring revision surgery. This author
cites 2 cases in his series where the patient
suffered instability and required a revision to a
more constrained prosthesis. He also recom-
mends that surgeons have a low tolerance for
using long-stem prosthesis (Figures 4 and 5). 
On  the  other  hand,  Kim
18 warns  against
using  highly  constrained  prostheses.  He
argues that the increased stress to the cement-
bone interface will eventuate in aseptic loos-
ening.  Furthermore,  the  considerable  bony
excision required for constrained prostheses
makes a revision difficult. One patient treated
with  a  hinged  prosthesis  in  his  series  is
reported as suffering a peri-prosthetic fracture
and subsequent aseptic loosening. He recom-
mends that hinged prostheses should be avoid-
ed if possible.
Custom augmentation of prostheses is also
common;
14,22 it  is  usually  required  to  repair
severe bony defects. The patella is also com-
monly replaced.
12,13
Conclusions
In conclusion, although technically demand-
ing and high risk, arthroplasty on a symptomatic
Charcot knee can be beneficial for the patient.
With the growing number of diabetic patients in
the population, the presentation of symptomatic
neuropathic arthropathy to the orthopaedic sur-
geon  is  likely  to  become  more  frequent.
Conservative  management  should  be  trialled
before surgery is considered. The surgeon must
be careful that the destructive phase of the dis-
ease  has  ceased  before  surgery  is  attempted,
and the patient must fully be aware of the risks
of failure. Meticulous attention should be direct-
ed  at  alignment  and  ligament  balancing.  A
Charcot  joint  should  not  be  considered  an
absolute contraindication to arthroplasty. 
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